Facial Injectable 2017 Global Market to Reach USD 9.0 billion and Growing at CAGR of 13.2% by 2021

WiseGuyReports.Com adds “Facial Injectable 2017 Global Market to Reach USD 9.0 billion and Growing at CAGR of 13.2% by 2021” Research to its Database.

Pune, India - January 12, 2018 /MarketersMedia/ —

Description:

Facial Injectable products, also known as dermal fillers are products that help in trending applications such as bioengineering or facial rejuvenation. With age, facial skin is bound to lose subcutaneous fat naturally and the skin is lured closer to the facial working muscles, thereby making smile lines and wrinkles over the face, more visible. This also leads to stretching of facial skin which adds to the loss of volume. These issues can be solved with the use facial injectable or dermal fillers. These products may also be used in treating early signs of ageing or as a value addition to a facial rejuvenation surgery.

The global facial injectable market is expected to reach USD 9.0 billion by 2021, growing at 13.2% CAGR during the forecast period.

On the basis of type, the global facial injectable market is segmented into botulinum toxin, hyaluronic acid, polymers & particles, and collagen. Botulinum toxin segment is estimated to hold the largest share within the global facial injectable market in 2016.

The market has been segmented on the basis of geography into North America, Europe, Asia-Pacific, and Middle East & Africa. North America is estimated to hold the largest market share of around 40% in 2016, while Asia-Pacific market is projected to register the fastest growth of 13.6% CAGR during the forecast period.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/877779-global-facial-injectable-market-estimation-forecast-2013-2021

For more information or any query mail at [email protected]

Key Players
The leading players of the global facial injectable market are Galderma S.A. (Switzerland), ALLERGAN (Ireland), Merz Pharma (Germany), Valeant (Canada), and Integra LifeSciences Corporation.(U.S.).

Study Objectives

• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
• To provide historical and forecast revenue of the market segments based on type, application, and end-users
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Target Audience

• Pharmaceutical companies
• Cosmetic Surgery Centers
• Potential Investors
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager

Key Findings

• North America market is projected to reach USD 3.4 billion by 2021, growing at the rate of 12.6% CAGR during the forecast period
• Asia-Pacific region is estimated to be valued at USD 786.7 million in 2016, and is expected to reach USD 1.6 billion by 2021
• Europe commands the second largest share of around 33% of global market in 2016

The reports also cover country level analysis:
• North America
• US
• Canada
• Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa

Ask Query @ https://www.wiseguyreports.com/enquiry/877779-global-facial-injectable-market-estimation-forecast-2013-2021

Table Of Contents – Major Key Points

1 MARKET OVERVIEW 12
1.1 PRODUCT OVERVIEW AND SCOPE OF FACIAL INJECTABLE 12
1.2 SPECIFICATIONS OF FACIAL INJECTABLE 13
1.2.1 HYALURONIC ACID 13
1.2.2 COLLAGEN 13
1.2.3 BOTULINUM TOXIN 13
1.2.4 POLYMERS AND PARTICLES 14

2 RESEARCH METHODOLGY 17
2.1 PRIMARY RESEARCH: 18
2.2 SECONDARY RESEARCH: 18

3 MARKET DYNAMICS 19
3.1 DRIVERS 19
3.1.1 GROWING DEMAND FOR FACIAL AESTHETIC TREATMENTS 19
3.1.2 TECHNOLOGICAL ADVANCEMENTS 19
3.1.3 EFFECTS OF POLLUTION 19
3.1.4 INCREASING ACCEPTANCE OF SOFT TISSUE FILLERS 20
3.1.5 GROWING DEMAND FOR DERMAL FILLER TECHNIQUES FROM ASIAN REGION 20
3.2 RESTRAINTS: 20
3.2.1 COMPLICATION DURING SURGERY 20
3.2.2 SIDE EFFECTS ASSOCIATED WITH FACIAL INJECTABLE 21
3.3 OPPORTUNITY 21
3.3.1 RISING AWARENESS ABOUT COMBINATION THERAPIES 21
3.4 PORTERS FIVE FORCES 22
3.5 BARGAINING POWER OF SUPPLIERS 23
3.6 BARGAINING POWER OF BUYERS 23
3.7 THREAT OF NEW ENTRANTS 23
3.8 THREAT OF SUBSTITUTES 23
3.9 INTENSITY OF RIVALRY 23
3.10 VALUE CHAIN ANALYSIS 24
3.10.1 INPUTS 24
3.10.2 DRUG DEVELOPMENT 24
3.10.3 MANUFACTURING PROCESS OF FACIAL INJECTABLE 24
3.10.4 MARKETING AND DISTRIBUTION 25
3.11 SUPPLY CHAIN 25

4 GLOBAL FACIAL INJECTABLE MARKET BY REGIONS 27
4.1 GLOBAL FACIAL INJECTABLE MARKET 27
4.2 NORTH AMERICA FACIAL INJECTABLE MARKET 29
4.3 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE 32
4.4 NORTH AMERICA FACIAL INJECTABLE MARKET, BY APPLICATION 35
4.5 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY: PRICE ($) 36
4.5.1 BOTULINUM TOXIN PRICE: BY COUNTRY ($) 36
4.5.2 HYALURONIC ACID PRICE: BY COUNTRY ($) 36
4.5.3 POLYMERS AND PARTICLES PRICE: BY COUNTRY ($) 37
4.5.4 COLLAGEN PRICE: BY COUNTRY ($) 37
4.6 NORTH AMERICA NUBER OF FACIAL INJECTABLE PROCEDURES BY COUNTRY, 2013-2021 38
4.6.1 BOTULINUM TOXIN 38
4.6.2 HYALURONIC ACID 38
4.6.3 POLYMERS & PARTICLES 38
4.6.4 COLLAGEN 39
4.7 US FACIAL INJECTABLE MARKET 40
4.7.1 U.S FACIAL INJECTABLE MARKET BY TYPE 40
4.7.2 U.S FACIAL INJECTABLE MARKET BY APPLICATIONU.S. FACIAL INJECTABLE MARKET, BY APPLICATION (USD MILLION) 41
4.7.3 U.S FACIAL INJECTABLE MARKET BYTYPE: PRICE ($) 42
4.8 CANADA FACIAL INJECTABLE MARKET 42
4.8.1 CANADA FACIAL INJECTABLE MARKET BY TYPE 42
4.8.2 CANADA FACIAL INJECTABLE MARKET BY APPLICATION 44
4.8.3 CANADA FACIAL INJECTABLE MARKET BY TYPE: PRICE ($) 45
4.9 EUROPE FACIAL INJECTABLE MARKET 45
4.9.1 EUROPE FACIAL INJECTABLE MARKET, BY TYPE 45
4.9.2 EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION 48
4.9.3 EUROPE FACIAL INJECTABLE MARKET, BY TYPE: PRICE ($) 50
4.10 EUROPE FACIAL INJECTABLE MARKET, BY COUNTRY (USD MILLION) 50
4.10.1 RUSSIA FACIAL INJECTABLE MARKET 50
4.10.2 GERMANY FACIAL INJECTABLE MARKET 51
4.10.3 FRANCE FACIAL INJECTABLE MARKET 51
4.10.4 U.K. FACIAL INJECTABLE MARKET 52
4.10.5 ITALY FACIAL INJECTABLE MARKET 52
4.10.6 SPAIN FACIAL INJECTABLE MARKET 53
4.10.7 REST OF EUROPE FACIAL INJECTABLE MARKET 53
4.11 EUROPE FACIAL INJECTABLE MARKET TYPES BY COUNTRY (VOLUME) 54
4.11.1 EUROPE HYALURONIC ACID 54
4.11.2 EUROPE BOTULINUM TOXIN 54
4.12 EUROPE FACIAL INJECTABLE MARKET BY APPLICATION (USD MILLION) 55
4.12.1 RUSSIA FACIAL INJECTABLE MARKET 55
4.12.2 GERMANY FACIAL INJECTABLE MARKET 55
4.12.3 FRANCE FACIAL INJECTABLE MARKET 55
4.12.4 U.K. FACIAL INJECTABLE MARKET 56
4.12.5 ITALY FACIAL INJECTABLE MARKET 56
4.12.6 SPAIN FACIAL INJECTABLE MARKET 56
4.12.7 REST OF EUROPE FACIAL INJECTABLE MARKET 57
4.13 ASIA FACIAL INJECTABLE MARKET 57
4.14 ASIA FACIAL INJECTABLE MARKET, BY TYPE 60
4.14.1 ASIA BOTULINUM TOXIN MARKET, BY COUNTRY 60
4.14.2 ASIA HYALURONIC ACID MARKET, BY COUNTRY 61
4.14.3 ASIA POLYMERS & PARTICLES MARKET, BY COUNTRY 62
4.14.4 ASIA COLLAGEN MARKET, BY COUNTRY 63
4.15 ASIA FACIAL INJECTABLE MARKET, BY APPLICATION 63
4.16 ASIA FACIAL INJECTABLE MARKET,BY TYPE: PRICE ($) 65
4.17 ASIA FACIAL INJECTABLE PROCEDURE: BY COUNTRY 66
4.17.1 SOUTH KOREA FACIAL INJECTABLE MARKET 68
4.17.2 JAPAN FACIAL INJECTABLE MARKET 69
4.17.3 CHINA FACIAL INJECTABLE MARKET 71
4.17.4 INDIA FACIAL INJECTABLE MARKET 72
4.17.5 REST OF ASIA FACIAL INJECTABLE MARKET 73

5 COMPETITIVE LANDSCAPE 75
5.1 GLOBAL FACIAL INJECTABLE MARKET COMPETITION BY MANUFACTURERS 75
5.1.1 GLOBAL FACIAL INJECTABLE SALES AND MARKET SHARE OF KEY MANUFACTURERS (2015 AND 2016) 75
5.2 GLOBAL FACIAL INJECTABLE MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 76

6 GLOBAL FACIAL INJECTABLE MARKET: COMPANY PROFILE 77
6.1 GALDERMA 77
6.1.1 COMPANY OVERVIEW 78
6.1.2 PRODUCT OVERVIEW 78
6.1.3 FINANCIALOVERVIEW 78
6.1.4 MANUFACTURING UNITS. 79
6.2 ALLERGAN 81
6.2.1 COMPANY OVERVIEW 81
6.2.2 PRODUCT OVERVIEW 82
6.2.4 KEY DEVELOPMENTS 83
6.3 MERZ PHARMA 84
6.3.1 COMPANY OVERVIEW 85
6.3.2 PRODUCT OVERVIEW 85
6.3.3 FINANCIAL OVERVIEW 86
6.3.4 KEY DEVLOPMENTS 87
6.3.5 MANUFACTURING UNITS 87
6.4 VALEANT PHARMACEUTICALS 88
6.4.1 COMPANY OVERVIEW 89
6.4.2 PRODUCT OVERVIEW 89
6.4.3 FINANCIAL OVERVIEW 90
6.4.4 KEY DEVELOPMENTS 90
6.4.5 MANUFACTURING UNITS 91
6.5 INTEGRA LIFESCIENCES 94
6.5.1 COMPANY OVERVIEW 94
6.5.2 PRODUCT OVERVIEW 94
6.5.4 KEY DEVELOPMENTS 95
6.5.5 MANUFACTURING UNITS 96

Continue…….

For more information or any query mail at [email protected]

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/facial-injectable-2017-global-market-to-reach-usd-9-0-billion-and-growing-at-cagr-of-13-2-by-2021/286823

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 286823